Interleukin-6 (IL-6) was one of the biomarkers of inflammation in the body (13, 14), and the binding of interleukin-6 to its receptor subunit alpha (IL-6Rα) plays a vital role in the development of IBD (15). This evidence concerns the gene IL6 and inflammatory bowel disease.